Our data further suggested that the combination can inhibit IRAK1/NF-κB and ERK signaling pathways, resulted in down-regulation of inflammatory factors and S100A7/9 expression, which are the main cytokines in tumor microenvironment contributed to CSC phenotype and function. This evidence concerns the gene NFKB1 and neoplasm.